Lindy Biosciences Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

Company Highlights
Year Founded

2017

icon-altEmployees

16

Location (HQ)

USA

Since Last Funding

2 years 7 months

Monthly Website Visitors

7.3K

icon-altTotal Investment Amt

$6.6M

Last Funding Round

Series B

icon-altYoY Headcount Growth

22.9%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Therapeutics

Research Services

Product Research

Research